According to the literature, an increase in CXCR3+CD8+ T cells has been identified as a biomarker that is associated with survival in melanoma patients with stage III disease (28), suggesting a potential role of this marker in the survival of patients infected with SARS-CoV-2. Here, CD8A is linked to melanoma.